Aristotle Capital Boston buys $11,025,941 stake in Amsurg Corp (AMSG)

Amsurg Corp (AMSG) : Aristotle Capital Boston scooped up 2,743 additional shares in Amsurg Corp during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Aug 15, 2016. The investment management firm now holds a total of 165,059 shares of Amsurg Corp which is valued at $11,025,941.Amsurg Corp makes up approximately 2.10% of Aristotle Capital Boston’s portfolio.

Other Hedge Funds, Including , Grandeur Peak Global Advisors reduced its stake in AMSG by selling 26,100 shares or 30.09% in the most recent quarter. The Hedge Fund company now holds 60,642 shares of AMSG which is valued at $4,050,886. Amsurg Corp makes up approx 0.82% of Grandeur Peak Global Advisors’s portfolio. Keybank National Associationoh sold out all of its stake in AMSG during the most recent quarter. The investment firm sold 6,344 shares of AMSG which is valued $423,779.Advisors Asset Management reduced its stake in AMSG by selling 108 shares or 3.74% in the most recent quarter. The Hedge Fund company now holds 2,779 shares of AMSG which is valued at $184,637.Her Majesty The Queen In Right Of The Province Of Alberta… boosted its stake in AMSG in the latest quarter, The investment management firm added 6,520 additional shares and now holds a total of 51,540 shares of Amsurg Corp which is valued at $3,726,857. Amsurg Corp makes up approx 0.05% of Her Majesty The Queen In Right Of The Province Of Alberta…’s portfolio.Dupont Capital Management Corp reduced its stake in AMSG by selling 1,742 shares or 5.95% in the most recent quarter. The Hedge Fund company now holds 27,558 shares of AMSG which is valued at $1,992,719. Amsurg Corp makes up approx 0.04% of Dupont Capital Management Corp’s portfolio.

Amsurg Corp opened for trading at $65.15 and hit $65.555 on the upside on Thursday, eventually ending the session at $65.4, with a gain of 0.74% or 0.48 points. The heightened volatility saw the trading volume jump to 21,30,521 shares. Company has a market cap of $3,585 M.

On the company’s financial health, Amsurg Corp reported $1.10 EPS for the quarter, beating the analyst consensus estimate by $ 0.02 according to the earnings call on Aug 2, 2016. Analyst had a consensus of $1.08. The company had revenue of $859.80 million for the quarter, compared to analysts expectations of $769.68 million. The company’s revenue was up 21.5% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.97 EPS.

Many Wall Street Analysts have commented on Amsurg Corp. Company shares were Reiterated by Mizuho on Jun 24, 2016 to “Buy”, Firm has raised the Price Target to $ 95 from a previous price target of $90 .Amsurg Corp was Upgraded by BofA/Merrill to ” Buy” on Jun 16, 2016. Amsurg Corp was Initiated by Wells Fargo to “Market Perform” on Jun 15, 2016.

AmSurg Corp. is the owner and operator of ambulatory surgery centers (ASCs) in the United States. The Company is also a provider of outsourced physician services in the areas of anesthesiology children’s services emergency medicine and radiology. The Company operates in two segments: ambulatory surgery services and outsourced physician services. The ambulatory services segment which acquires develops and operates ambulatory surgery centers in partnership with physicians. The physician services segment which provides outsourced physician services in multiple specialties to hospitals ambulatory surgery centers and other healthcare facilities primarily in the areas of anesthesiology children’s services emergency medicine and radiology. It operated approximately 246 ASCs in over 34 states and the District of Columbia in partnership with approximately 2000 physicians and provided physician services to over 320 healthcare facilities in 24 states.

Leave a Reply

Amsurg Corp - Is it time to Sell?

Top Brokerage Firms are advising their investors on Amsurg Corp. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.